GYG1 causing progressive limb girdle myopathy with onset during teenage years (polyglucosan body myopathy 2)

Neuromuscul Disord. 2018 Apr;28(4):346-349. doi: 10.1016/j.nmd.2018.01.002. Epub 2018 Jan 10.

Abstract

An 84-year-old lady with slowly progressive limb and axial muscle weakness with onset in her teens was referred for genetic investigations. Targeted next generation sequencing (NGS) revealed a homozygous mutation GYG1 in exon5:c.487delG:p.D163fs, confirming the diagnosis of Polyglucosan Body Myopathy 2 (PGBM2). Retrospective review of muscle pathology revealed a florid vacuolar myopathy with histochemical and ultrastructural features consistent with a polyglucosan storage myopathy. No cardiac symptoms were reported. Our case is consistent with the core phenotype of GYG1-related PGBM2 apart from an early onset of weakness without cardiac symptoms. The presence of α-amylase resistant PAS-positive material in skeletal muscle biopsy of patients with slowly progressive limb girdle muscle weakness should prompt the search for GYG1 mutations. This case highlights the combined role of muscle pathology and NGS in the molecular resolution of patients with undiagnosed neuromuscular conditions.

Keywords: Glycogen storage disease; Limb girdle muscle weakness; Polyglucosan body myopathy; Progressive muscle weakness.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Female
  • Glucosyltransferases / genetics*
  • Glycogen Storage Disease / diagnosis
  • Glycogen Storage Disease / genetics*
  • Glycoproteins / genetics*
  • Humans
  • Muscle Weakness / pathology
  • Muscle, Skeletal / pathology
  • Muscular Atrophy / genetics*
  • Muscular Atrophy / pathology
  • Muscular Diseases / diagnosis
  • Muscular Diseases / genetics*
  • Mutation / genetics
  • Retrospective Studies

Substances

  • Glycoproteins
  • glycogenin
  • Glucosyltransferases